Public Access To FDA Compliance, Enforcement Data Would Grow Under New Proposals
This article was originally published in The Gray Sheet
Executive SummaryFDA’s Transparency Task Force is floating ideas for making the agency’s compliance and enforcement data more accessible to the public.
You may also be interested in...
FDA issues final rule on Strategic National Stockpile of devices, drugs and biologics. Commissioner adopts proposals to make compliance data more transparent. More regulatory briefs.
The head of the European Medicines Agency is nearing the end of his tenure. We consider Guido Rasi’s achievements over the past 10 years as well as the controversies that have arisen under his leadership – and report that sailing is likely to figure in his plans for life after the agency.